Open AccessA novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models
Author(s) -
Somi Cho,
Eunkyeong Jang,
TaeYoung Yoon,
Haejun Hwang,
Jeehee Youn
Publication year - 2022
Publication title -
clinical and experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1093/cei/uxac096
Subject(s) - syk , autoantibody , medicine , immunology , systemic lupus erythematosus , rheumatoid arthritis , arthritis , autoimmunity , lupus nephritis , germinal center , spleen , immune system , tyrosine kinase , antibody , b cell , receptor , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom